Will Pfizer (PFE) Surpass Estimates This Earnings Season?

While Pfizer’s (PFE) new drugs like Ibrance and Xeljanz are likely to drive sales in Q4, genericization of key drugs and supply shortages in legacy Hospira products will hurt sales.